The Endothelial Glycocalyx is a Gel-like Layer at the Luminal Side of Endothelial Cells Lining the Blood Vessels Throughout the Body.
Video of microvascular (microscopic capillary) blood flow captured by the GlycoCheck™ camera.
Years of Research and Development on the Glycocalyx
Square Feet of Glycocalyx: The Largest Surface Area of Any Organ
Miles of
Glycocalyx: The Longest Organ in the Body
Citations Worldwide Verifying Glycocalyx Role
The original black and white images of the glycocalyx above were colorized to provide greater detail and clarity. Colorization helps to distinguish various structures and components within the glycocalyx, making it easier to identify and analyze specific features
The glycocalyx, a complex layer of sugars and proteins coating the inner surface of blood vessels, plays a critical role in the health of cells, tissues, and organs through its influence on microcirculation. Microcirculation refers to the flow of blood through the smallest vessels in the body, the capillaries, which are crucial for delivering nutrients and oxygen to cells and removing waste products.
The original black and white images of the glycocalyx above were colorized to provide greater detail and clarity. Colorization helps to distinguish various structures and components within the glycocalyx, making it easier to identify and analyze specific features
When the glycocalyx is healthy, it ensures efficient and smooth blood flow through capillaries, which make up 99% of the body's total circulatory system.
This optimal blood flow allows for the effective delivery of nutrients and oxygen to every cell and aids in the removal of toxins and waste products. Consequently, the cells, tissues, and organs maintain their health and function properly.
However, if the glycocalyx becomes damaged or compromised, this negatively impacts the microcirculation. The damaged glycocalyx leads to impaired capillary function, where blood flow is restricted or altered.
This reduction in microcirculation means that cells receive less oxygen and nutrients, and the removal of toxic waste products is hindered.
Over time, this can contribute to the development of various diseases, as cells and tissues are unable to function optimally due to the lack of essential supplies and the buildup of harmful substances.
Microscopic capillaries, making up 99% of our circulatory system, are essential for distributing oxygen and nutrients and eliminating toxins from the body. However, when the glycocalyx is impaired, this crucial capillary circulation is reduced, leading to the deterioration of cells, tissues, and organs, which can result in numerous diseases and eventual death.
The Endothelial Glycocalyx is a Gel-like Layer at the Luminal Side of Endothelial Cells
Lining the Blood Vessels Throughout the Body.
Video of microvascular (microscopic capillary) blood flow
captured by the GlycoCheck™ camera.
Years of Research and Development on the Glycocalyx
Square Feet of Glycocalyx: The Largest Surface Area of Any Organ
Miles of
Glycocalyx: The Longest Organ in the Body
Citations Worldwide Verifying Glycocalyx Role
The original black and white images of the glycocalyx above were colorized to provide greater detail and clarity. Colorization helps to distinguish various structures and components within the glycocalyx, making it easier to identify and analyze specific features
The original black and white images of the glycocalyx above were colorized to provide greater detail and clarity. Colorization helps to distinguish various structures and components within the glycocalyx, making it easier to identify and analyze specific features
Cross-section of a capillary blood vessel shows extensive dimension of the glycocalyx in a healthy blood vessel.
High magnification showing the dimension of the glycocalyx's several fold thickness of the endothelium.
Cross-section of a capillary blood vessel shows extensive dimension of the glycocalyx in a healthy blood vessel.
High magnification showing the dimension of the glycocalyx's several fold thickness of the endothelium.
The glycocalyx, a complex layer of sugars and proteins coating the inner surface of blood vessels, plays a critical role in the health of cells, tissues, and organs through its influence on microcirculation. Microcirculation refers to the flow of blood through the smallest vessels in the body, the capillaries, which are crucial for delivering nutrients and oxygen to cells and removing waste products.
The original black and white images of the glycocalyx above were colorized to provide greater detail and clarity. Colorization helps to distinguish various structures and components within the glycocalyx, making it easier to identify and analyze specific features
Healthy Glycocalyx
Unhealthy Glycocalyx
When the glycocalyx is healthy, it ensures efficient and smooth blood flow through capillaries, which make up 99% of the body's total circulatory system.
This optimal blood flow allows for the effective delivery of nutrients and oxygen to every cell and aids in the removal of toxins and waste products. Consequently, the cells, tissues, and organs maintain their health and function properly.
However, if the glycocalyx becomes damaged or compromised, this negatively impacts the microcirculation. The damaged glycocalyx leads to impaired capillary function, where blood flow is restricted or altered.
This reduction in microcirculation means that cells receive less oxygen and nutrients, and the removal of toxic waste products is hindered.
Over time, this can contribute to the development of various diseases, as cells and tissues are unable to function optimally due to the lack of essential supplies and the buildup of harmful substances.
Microscopic capillaries, making up 99% of our circulatory system, are essential for distributing oxygen and nutrients and eliminating toxins from the body. However, when the glycocalyx is impaired, this crucial capillary circulation is reduced, leading to the deterioration of cells, tissues, and organs, which can result in numerous diseases and eventual death.
Click on the blue button to read a study or scientific paper on the relationship between the glycocalyx and the health condition.
Dr. Hans Vink, Director of Advanced Glycocalyx Research at the Glycocalyx Research Institute, has been instrumental in developing and refining GlycoCheck™, a patented, non-invasive, FDA Class 1 medical device that evaluates the health of the glycocalyx.
Additionally, he and his team have innovated a nutraceutical, proven effective in numerous global clinical studies, for repairing and restoring the function of the glycocalyx, thus significantly aiding in the rejuvenation of health previously compromised by glycocalyx impairment. This nutraceutical's latest iteration is known as ReVasca™.
Dr. Hans Vink, Director of Advanced Glycocalyx Research at the Glycocalyx Research Institute, has been instrumental in developing and refining GlycoCheck™, a patented, non-invasive, FDA Class 1 medical device that evaluates the health of the glycocalyx.
Available in Capsules &
Natural Grape Drink Powder
Additionally, he and his team have innovated a nutraceutical, proven effective in numerous global clinical studies, for repairing and restoring the function of the glycocalyx, thus significantly aiding in the rejuvenation of health previously compromised by glycocalyx impairment. This nutraceutical's latest iteration is known as ReVasca™.
Dr. Hans Vink
Robert Long
Co-Founder, Director of Advanced Research
Dr. Vink is a glycocalyx research pioneer, the world’s leading glycocalyx researcher, and the inventor of the GlycoCheck™ testing device. He has published over 250 scholarly papers on the glycocalyx, and his research has been cited in more than 16,000 citations. Download Dr. Vink's CV
Co-Founder, Director of Nutraceutical Research
Robert Long is a research collaborator with Dr. Vink and the developer of the glycocalyx-regenerating nutraceuticals, the latest refinement being ReVasca™. He formulated the glycocalyx nutraceuticals, and Dr. Vink validated their efficacy with GlycoCheck™..
Dr. Hans Vink
Co-Founder, Director of Advanced Research
Dr. Vink is a glycocalyx research pioneer, the world’s leading glycocalyx researcher, and the inventor of the GlycoCheck™ testing device. He has published over 250 scholarly papers on the glycocalyx, and his research has been cited in more than 16,000 citations. Download Dr. Vink's CV
Robert Long
Co-Founder, Director of Nutraceutical Research
Robert Long is a research collaborator with Dr. Vink and the developer of the glycocalyx-regenerating nutraceuticals, the latest refinement being ReVasca™. He formulated the glycocalyx nutraceuticals, and Dr. Vink validated their efficacy with GlycoCheck™.
Currently, over 140 hospitals and universities are conducting glycocalyx research using GlycoCheck™ and the Glycocalyx Research Institute's glycocalyx-restoring nutraceuticals.
The studies are focused on the following health issues: Type 2 Diabetes, Hypertension, Stroke, Kidney Failure, Syndrome X, Sepsis/Septic Shock, Inflammatory Disease, Malaria/Dengue, and Obesity.
The research indicates that glycocalyx health is crucial for overall well-being and in managing diseases related to aging. GlycoCheck™ effectively measures glycocalyx health, and the nutraceuticals developed by Dr. Vink and Robert Long aid in restoring it.
GlycoCheck™ is being used by researchers in hospitals and universities in Africa, Asia, Australia, China, Europe, Japan, Russia, and the United States.
Currently, over 140 hospitals and universities are conducting glycocalyx research using GlycoCheck™ and the Glycocalyx Research Institute's glycocalyx-restoring nutraceuticals.
The studies are focused on the following health issues: Type 2 Diabetes, Hypertension, Stroke, Kidney Failure, Syndrome X, Sepsis/Septic Shock, Inflammatory Disease, Malaria/Dengue, and Obesity.
The research indicates that glycocalyx health is crucial for overall well-being and in managing diseases related to aging. GlycoCheck™ effectively measures glycocalyx health, and the nutraceuticals developed by Dr. Vink and Robert Long aid in restoring it.
GlycoCheck™ is being used by researchers in hospitals and universities in Africa, Asia, Australia, China, Europe, Japan, Russia, and the United States.
Click on a medical condition below to see Glycocheck™ studies related to that condition.
Click on a medical condition below to see Glycocheck™ studies related to that condition.
GlycoCheck™ is a non-invasive medical device used to analyze the microvascular health by examining the glycocalyx. The glycocalyx is a microscopic gel-like layer that lines the endothelium (inner wall) of blood vessels and is crucial for vascular health
Administration: To use GlycoCheck™, a specialized video microscope is placed under the tongue. This location is chosen because the capillaries here are close to the surface and easy to access.
FUNCTIONING: Once the microscope is in place, it captures real-time, high-resolution video images of blood flow in the capillaries. These images are then analyzed using advanced software.
Measurement & Analysis: GlycoCheck™ measures the Microvascular Health Score (MVHS), which reflects the condition of the glycocalyx. It does this by assessing factors like the
perfused boundary region (PBR), which indicates how deep red blood cells can penetrate the glycocalyx. Deeper penetration indicates more glycocalyx damage.
Outcome: By providing a detailed analysis of the glycocalyx and capillary function, GlycoCheck™ helps in the early detection of microvascular issues and guides healthcare professionals in prescribing therapeutic options.
GlycoCheck™ is a non-invasive medical device used to analyze the microvascular health by examining the glycocalyx. The glycocalyx is a microscopic gel-like layer that lines the endothelium (inner wall) of blood vessels and is crucial for vascular health
Administration: To use GlycoCheck™, a specialized video microscope is placed under the tongue. This location is chosen because the capillaries here are close to the surface and easy to access.
FUNCTIONING: Once the microscope is in place, it captures real-time, high-resolution video images of blood flow in the capillaries. These images are then analyzed using advanced software.
Measurement & Analysis: GlycoCheck™ measures the Microvascular Health Score (MVHS), which reflects the condition of the glycocalyx. It does this by assessing factors like the perfused boundary region (PBR), which indicates how deep red blood cells can penetrate the glycocalyx. Deeper penetration indicates more glycocalyx damage.
Outcome: By providing a detailed analysis of the glycocalyx and capillary function, GlycoCheck™ helps in the early detection of microvascular issues and guides healthcare professionals in prescribing therapeutic options.
CAPSULES NATURAL GRAPE DRINK POWDER
ReVasca™ is Dr. Vink's and Robert Long's next-generation nutraceutical designed to support and repair the glycocalyx. It represents the advancement in glycocalyx-focused supplements, succeeding the original formulations known as Arterosil and Endocalyx Pro.*
Composition and Function: ReVasca™ contains a blend of specific nutrients and natural compounds essential for maintaining and repairing the glycocalyx. These ingredients are formulated to work synergistically to support the glycocalyx's structure, thereby enhancing its protective functions. This includes improving the barrier function, which is crucial for regulating the flow of substances between the bloodstream and surrounding tissues*.
Advancements Over Endocalyx Pro™: Having been in use for over 10 years, Endocalyx Pro™. established a foundational revolution in glycocalyx health. However, ReVasca™ incorporates recent advances in nutraceutical technology and new insights from Dr. Hans Vink's research. Dr. Vink believes these developments will make ReVasca™ more effective than its predecessor, offering in his opinion, improved efficacy in supporting and repairing the glycocalyx.
Administration: ReVasca™ is administered orally. It comes in capsules and in a powdered drink formulation that is easy to integrate into daily routines.
Benefits: By repairing and maintaining the health of the glycocalyx, ReVasca™ helps ensure efficient microcirculation. This, in turn, aids in the optimal delivery of nutrients and oxygen to cells, proper removal of waste products, and overall vascular health, potentially reducing the risk of various microvascular-related conditions.*
In summary, ReVasca™ represents a significant step forward in glycocalyx health, promising to offer enhanced benefits over its predecessors, Arterosil and Endocalyx Pro both formulated by Dr. Hans Vink and Robert Long.*
WHOLESALE PROGRAM
Register to Provide ReVasca Directly to Your Patients
PARTNER PROGRAM
Register to Recommend ReVasca And We Drop Ship
WHOLESALE PROGRAM
Register to Provide ReVasca Directly to Your Patients
PARTNER PROGRAM
Register to Recommend ReVasca And We Drop Ship
CONSUMERS/PATIENTS
Order Directly From ReVasca.com
Call to Order By Phone (833) 424-5926
WHOLESALE PROGRAM
Register to Provide ReVasca Directly to Your Patients
PARTNER PROGRAM
Register to Recommend ReVasca And We Drop Ship
CONSUMERS/PATIENTS
Order Directly From ReVasca.com
Call to Order By Phone (833) 424-5926
CAPSULES NATURAL GRAPE DRINK POWDER
ReVasca™ is Dr. Vink's and Robert Long's next-generation nutra-ceutical designed to support and repair the glycocalyx. It represents the advancement in glycocalyx-focused supplements, succeeding the original formulations known as Arterosil and Endocalyx Pro.*
Composition and Function: ReVasca™ contains a blend of specific nutrients and natural compounds essential for maintaining and repairing the glycocalyx. These ingredients are formulated to work synergistically to support the glycocalyx's structure, thereby enhancing its protective functions. This includes improving the barrier function, which is crucial for regulating the flow of substances between the bloodstream and surrounding tissues*.
Advancements Over Endocalyx Pro™: Having been in use for over 10 years, Endocalyx Pro™. established a foundational revolution in glycocalyx health. However, ReVasca™ incorporates recent advances in nutraceutical technology and new insights from Dr. Hans Vink's research. Dr. Vink believes these developments will make ReVasca™ more effective than its predecessor, offering in his opinion, improved efficacy in supporting and repairing the glycocalyx.
Administration: ReVasca™ is administered orally. It comes in capsules and in a powdered drink formulation that is easy to integrate into daily routines.
Benefits: By repairing and maintaining the health of the glycocalyx, ReVasca™ helps ensure efficient microcirculation. This, in turn, aids in the optimal delivery of nutrients and oxygen to cells, proper removal of waste products, and overall vascular health, potentially reducing the risk of various microvascular-related conditions.*
In summary, ReVasca™ represents a significant step forward in glycocalyx health, promising to offer enhanced benefits over its predecessors, Arterosil and Endocalyx Pro both formulated by Dr. Hans Vink and Robert Long.*
WHOLESALE PROGRAM
Register to Provide ReVasca Directly to Your Patients
PARTNER PROGRAM
Register to Recommend ReVasca And We Drop Ship
WHOLESALE PROGRAM
Register to Provide ReVasca Directly to Your Patients
PARTNER PROGRAM
Register to Recommend ReVasca And We Drop Ship
CONSUMERS/PATIENTS
Order Directly From ReVasca.com
Call to Order By Phone
(833) 424-5926
ABOUT THE
The Glycocalyx Research Institute, founded in 2012 and led by Dr. Hans Vink and Robert Long, aims to provide education and training on the endothelium glycocalyx and the microvascular system, as well as consult and design glycocalyx and microvascular-based research studies.
The Institute creates and delivers medical devices and nutritional supplements that monitor and support the health and well-being of the endothelial glycocalyx and the microvascular system.
The company’s flagship product is GlycoCheck™, a clinically validated, class-one medical device that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx.
With the revolutionary patented imaging software and hardware system developed by Dr. Hans Vink, healthcare professionals can identify and monitor the contribution of microvascular dysfunction and glycocalyx damage during disease development.
The Glycocalyx Research Institute has also developed a game-changing, proprietary, anti-aging supplement, ReVasca™, which delivers the anti-aging building blocks essential to maintaining a healthy endothelial glycocalyx and capillaries in the microvascular system.
This unique combination of GlycoCheck™ and the ReVasca™ nutraceutical has proven to be successful in restoring, regenerating, and protecting the glycocalyx gel lining of the microvascular system in order to prevent organ starvation.
ABOUT THE
The Glycocalyx Research Institute, founded in 2012 and led by Dr. Hans Vink and Robert Long, aims to provide education and training on the endothelium glycocalyx and the microvascular system, as well as consult and design glycocalyx and microvascular-based research studies.
The Institute creates and delivers medical devices and nutritional supplements that monitor and support the health and well-being of the endothelial glycocalyx and the microvascular system.
The company’s flagship product is GlycoCheck™, a clinically validated, class-one medical device that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx.
With the revolutionary patented imaging software and hardware system developed by Dr. Hans Vink, healthcare professionals can identify and monitor the contribution of microvascular dysfunction and glycocalyx damage during disease development.
The Glycocalyx Research Institute has also developed a game-changing, proprietary, anti-aging supplement, ReVasca™, which delivers the anti-aging building blocks essential to maintaining a healthy endothelial glycocalyx and capillaries in the microvascular system.
This unique combination of GlycoCheck™ and the ReVasca™ nutraceutical has proven to be successful in restoring, regenerating, and protecting the glycocalyx gel lining of the microvascular system in order to prevent organ starvation.
If you are a healthcare professional or university researcher interested in learning more about GlycoCheck™ and Revasca™, please fill out and submit the form below. We will promptly respond to your inquiry.
If you are a healthcare professional or university researcher interested in learning more about GlycoCheck™ and Revasca™, please fill out and submit the form below. We will promptly respond to your inquiry.
Copyright 2024 GlycoCalyx Research Institute | All Rights Reserved
Privacy Policy | Terms and Conditions
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”; and these statemenst do not claim to diagnose, mitigate, treat, cure, or prevent a specific disease or class of diseases.
Copyright 2024 GlycoCalyx Research Institute | All Rights Reserved
Privacy Policy | Terms and Conditions
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”; and these statemenst do not claim to diagnose, mitigate, treat, cure, or prevent a specific disease or class of diseases.